Label Changes for:
Tenex (guanfacine hydrochloride) Tablets
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
- Hallucinations have been reported in pediatric patients receiving Tenex for treatment of attention-deficit hyperactivity disorder